<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">subtype </span>
   <span class="font29">resistance </span>
   <span class="font19">HIV- </span>
   <span class="font19">drug </span>
   <span class="font18">mutations </span>
   <span class="font18">subtypes </span>
   <span class="font16">[]. </span>
   <span class="font15">mutation </span>
   <span class="font15">patients </span>
   <span class="font15">non-B </span>
   <span class="font15">HIV </span>
   <span class="font14">antiretroviral </span>
   <span class="font14">type </span>
   <span class="font13">reverse </span>
   <span class="font13">viruses </span>
   <span class="font13">polymorphisms </span>
   <span class="font13">transcriptase </span>
   <span class="font13">{border-style </span>
   <span class="font13">[â€“]. </span>
   <span class="font13">different </span>
   <span class="font13">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">PIs </span>
   <span class="font12">protease </span>
   <span class="font12">studies </span>
   <span class="font12">therapy </span>
   <span class="font12">differences </span>
   <span class="font12">higher </span>
   <span class="font12">Infect </span>
   <span class="font12">Res </span>
   <span class="font12">clinical </span>
   <span class="font12">failure </span>
   <span class="font12">virus </span>
   <span class="font12">Dis </span>
   <span class="font12">Hum </span>
   <span class="font12">data </span>
   <span class="font12">drugs </span>
   <span class="font12">genetic </span>
   <span class="font12">human </span>
   <span class="font12">immunodeficiency </span>
   <span class="font12">isolates </span>
   <span class="font12">reported </span>
   <span class="font12">study </span>
   <span class="font11">lower </span>
   <span class="font11">nevirapine </span>
   <span class="font11">Retrovirus </span>
   <span class="font11">background </span>
   <span class="font11">frequency </span>
   <span class="font11">infected </span>
   <span class="font11">Agents </span>
   <span class="font11">CRF_AG </span>
   <span class="font11">Chemother </span>
   <span class="font11">cross-resistance </span>
   <span class="font11">development </span>
   <span class="font11">failing </span>
   <span class="font11">major </span>
   <span class="font11">natural </span>
   <span class="font11">non-subtype </span>
   <span class="font11">selection </span>
   <span class="font11">treatment </span>
   <span class="font11">viral </span>
   <span class="font11">Acquir </span>
   <span class="font11">CRF_AE </span>
   <span class="font11">Defic </span>
   <span class="font11">However, </span>
   <span class="font11">Immune </span>
   <span class="font11">Syndr </span>
   <span class="font11">compared </span>
   <span class="font11">emergence </span>
   <span class="font11">impact </span>
   <span class="font11">pathways </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">NNRTIs </span>
   <span class="font11">NVP </span>
   <span class="font11">South </span>
   <span class="font11">font-size </span>
   <span class="font11">important </span>
   <span class="font11">inhibitors </span>
   <span class="font11">mutations. </span>
   <span class="font11">regard </span>
   <span class="font11">subtypes, </span>
   <span class="font11">subtypes. </span>
   <span class="font11">susceptibility </span>
   <span class="font11">template </span>
   <span class="font11">treated </span>
   <span class="font11">variants </span>
   <span class="font11">Botswana </span>
   <span class="font11">Gag </span>
   <span class="font11">NFV </span>
   <span class="font11">NNRTI </span>
   <span class="font11">NRTI </span>
   <span class="font11">acquisition </span>
   <span class="font11">associated </span>
   <span class="font11">combinations </span>
   <span class="font11">differential </span>
   <span class="font11">diversity </span>
   <span class="font11">double; </span>
   <span class="font11">first-line </span>
   <span class="font11">genotypic </span>
   <span class="font11">infections </span>
   <span class="font11">observed </span>
   <span class="font11">phenotypic </span>
   <span class="font11">potential </span>
   <span class="font11">rates </span>
   <span class="font11">residues </span>
   <span class="font11">single-dose </span>
   <span class="font11">specific </span>
   <span class="font11">susceptibilities </span>
   <span class="font11">virological </span>
   <span class="font11">vitro </span>
   <span class="font11">women </span>
   <span class="font10">(e.g., </span>
   <span class="font10">ARVs </span>
   <span class="font10">Africa </span>
   <span class="font10">Ethiopian </span>
   <span class="font10">Resistance </span>
   <span class="font10">accumulation </span>
   <span class="font10">affect </span>
   <span class="font10">appear </span>
   <span class="font10">backbones </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">certain </span>
   <span class="font10">codon </span>
   <span class="font10">fact </span>
   <span class="font10">high </span>
   <span class="font10">individuals </span>
   <span class="font10">information </span>
   <span class="font10">levels </span>
   <span class="font10">line </span>
   <span class="font10">mother-to-child </span>
   <span class="font10">need </span>
   <span class="font10">nonnucleoside </span>
   <span class="font10">polymorphism </span>
   <span class="font10">pressure </span>
   <span class="font10">recombinant </span>
   <span class="font10">seen </span>
   <span class="font10">solid; </span>
   <span class="font10">southern </span>
   <span class="font10">testing </span>
   <span class="font10">use </span>
   <span class="font10">versus </span>
   <span class="font10">virologic </span>
   <span class="font10">vs. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">ARV </span>
   <span class="font10">Med </span>
   <span class="font10">NRTIs </span>
   <span class="font10">Subtype </span>
   <span class="font10">VI, </span>
   <span class="font10">Virol </span>
   <span class="font10">act </span>
   <span class="font10">assays </span>
   <span class="font10">available </span>
   <span class="font10">basis </span>
   <span class="font10">bold </span>
   <span class="font10">courier; </span>
   <span class="font10">degree </span>
   <span class="font10">detected </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">genotypes </span>
   <span class="font10">immigrants </span>
   <span class="font10">magnitude </span>
   <span class="font10">molecular </span>
   <span class="font10">nucleoside </span>
   <span class="font10">overall </span>
   <span class="font10">pathway </span>
   <span class="font10">performed </span>
   <span class="font10">positions </span>
   <span class="font10">present </span>
   <span class="font10">prevalence </span>
   <span class="font10">primary </span>
   <span class="font10">profile </span>
   <span class="font10">propensity </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">regimen </span>
   <span class="font10">regimens </span>
   <span class="font10">regimens, </span>
   <span class="font10">risk </span>
   <span class="font10">secondary </span>
   <span class="font10">selected </span>
   <span class="font10">single </span>
   <span class="font10">transmission </span>
   <span class="font10">used </span>
  </p>
 </body>
</html>
